LINE

Text:AAAPrint
Sci-tech

Myanmar, China jointly produce COVID-19 vaccines

1
2022-03-23 21:49:09Xinhua Editor : Xue Lingqiao ECNS App Download
Special: Battle Against Novel Coronavirus

Myanmar launched the production of Myancopharm COVID-19 vaccines here on Wednesday at Myanmar Pharmaceutical Industry (MPI) in collaboration with China.

Lt.-Gen. Aung Lin Dwe, secretary of the State Administration Council (SAC), said Myanmar has trialed and produced COVID-19 vaccines domestically in cooperation with Sinopharm CNBG.

"Technology for vaccine production was obtained and foreign currency use would be reduced as Myancopharm COVID-19 vaccines were successfully produced in the country," he said.

Chinese Ambassador Chen Hai said Sinopharm's cooperative Ready to Fill (RTF) Bulk vaccine plant with Myanmar is the Chinese pharmaceutical company's first COVID-19 vaccine plant officially put into operation in the Asia-Pacific, which will help Myanmar strengthen its capacity to independently produce vaccines.

Union Minister for Ministry of Industry Charlie Than said the ministry and Sinopharm CNBG signed the agreement of RTF Bulk purchase for the production of COVID-19 vaccines in Myanmar on Dec. 22 last year.

The ministry will be manufacturing 1 million doses of vaccine per month, targeting 10 million doses for 2022-2023 Fiscal Year. The vaccines will be distributed to the Ministry of Health starting in April, he stressed.

As of March 19, over 21.6 million people have been fully vaccinated against COVID-19 across the country, according to the Ministry of Health. 

MorePhoto

Most popular in 24h

MoreTop news

MoreVideo

LINE
Back to top About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2022 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证(0106168)] [京ICP证040655号]
[京公网安备 11010202009201号] [京ICP备05004340号-1]